International Clinical Trial: Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214688) titled 'Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies' on Oct. 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Hackensack Meridian Health

Condition: Allogeneic Stem Cell Transplant Recipient

Intervention: Drug: Fludarabine Radiation: Intermediate-dose Total Body Irradiation (TBI) Drug: Post-transplant Cyclophosphamide (PTCy) Drug: Tacrolimus

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: ...